Showing 291-300 of 4161 results for "".
Should You Hire a Scribe?
https://modernaesthetics.com/ma-issues-index/2023-may-june/should-you-hire-a-scribe-1/35280/What to consider before bringing a scribe into your practice and the benefits of doing so.LGBTQ+ Facial Visualization and Optimizing Satisfaction
https://beta.modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/lgbtq-facial-visualization-and-optimizing-satisfaction/33937/In recognition of Pride Month, and as part of our ongoing efforts toward inclusivity, we continue our talk with Washington, DC-based facial plastic surgeon Michael Somenek, MD. Listen as he describes the importance of recognizing gender fluidity and explains his method of visualizing the face toLet’s Talk About Plastic Surgery
https://beta.modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/lets-talk-about-plastic-surgery/33933/Once plastic surgery was only discussed in hushed tones and behind closed doors, but times are changing. Today’s plastic surgery patients are eager to talk about what they have had done and by whom. Many even share their before and afters on social media. New York City plastic surgeon Ryan NeinstThe No Surprises Act and Aesthetic Patients
https://beta.modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/the-no-surprises-act-and-aesthetic-patients/33932/In December 2020, Congress passed the No Surprises Act as part of a larger COVID-19 relief package. This Act reduces the occurrence of surprise bills after a medical service or procedure, and it affects aesthetics a lot more than most people realize. San Franciso plastic surgeon Jonathan Kaplan,Shielding Your Wealth From Potential Liability
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/shielding-your-wealth-from-potential-liability/35233/The basics of a solid asset protection plan.MATV News: Endo Pulls Qwo from Market; Merz Aesthetics Adds SaltFacial; Current Trends in Aesthetic Medicine
https://beta.modernaesthetics.com/series/matv-news/matv-news-endo-pulls-qwo-from-market-merz-aesthetics-adds-saltfacial-current-trends-in-aesthetic-medicine/33713/Endo International is ceasing the production and sale of Endo Aesthetics' injectable cellulite treatment Qwo; Merz Aesthetics is adding the SaltFacial to its portfolio through an extended commercial agreement with SaltMED; and New York City dermatologist Dr. Robert Finney discusses trends in aesthetMATV News: AAFPRS President Dr. Theda Kontis Takes Office; Aesthetic Society and ASERF Unveil BII Study Results; The Role of AI in Skincare
https://beta.modernaesthetics.com/series/matv-news/matv-news-aafprs-president-dr-theda-kontis-takes-office-aesthetic-society-and-aserf-unveil-bii-study-results-the-role-of-ai-in-skincare/33710/New AAFPRS President Dr. Theda Kontis shares goals for her term, the Aesthetic Society and ASERF unveil findings from the Biospecimen study on breast implant illness; and a new report from Perfect Corp. looks at the growing role artificial intelligence and digital skin analysis is playing in risingA Cosmetic Surgery Boom
https://beta.modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/a-cosmetic-surgery-boom/33930/New data from the American Society of Plastic Surgeons show business is good for aesthetic physicians. In fact, more than three-quarters of cosmetic-focused plastic surgery practices are seeing more business than before the pandemic. Bob Basu, MD, a plastic surgeon in Houston, TX, discusses the tMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://beta.modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://beta.modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile Pro